Menu

Latest news & events

Social and economic background influences survival in intensive care: Research with societal impact

Social and economic background influences survival in intensive care: Research with societal impact

18 August 2026

A large-scale study by researchers from Maastricht UMC+ and Amsterdam UMC demonstrates that lower socioeconomic status (SES) of patients admitted to Dutch intensive care units contributes to worse survival.

Read more
Fatma Karapinar appointed as Professor in Medication Safety

Fatma Karapinar appointed as Professor in Medication Safety

12 August 2026

As of 1 June 2026, Dr Fatma Karapinar has been appointed Professor of Medication Safety at Maastricht University.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Arnoud van 't Hof

Professor

Prof. Arnoud van ‘t Hof is Interventional Cardiologist and head of the department of Interventional Cardiology in Maastricht University Medical Center and Zuyderland Medical Center in Heerlen, the Netherlands. He has a long-standing research history in cardiovascular medicine, particularly in the field of primary angioplasty and acute coronary syndromes, with special interest in pre-hospital diagnosis and triage in the ambulance. He has been (co-) chairing international multi-center clinical trials in this field. He is a board member of the Acute Cardiac Care Association (ACCA) and editorial board member of the European Heart Journal Acute Cardiovascular Care and the Netherlands Heart Journal. He chaired the board of directors of the National Cardiovascular Data Registry (NCDR, now Nederlandse Hart Registratie (NHR) with specific interest for value based healthcare (VBHC) and data science. He recently joined the European Association of Preventive Cardiology (EAPC) with research on Cardiac Rehabilitation, Cardiovascular Prevention and Sports Medicine.

Prof. Arnoud van ‘t Hof has authored over 350 publications in peer-reviewed cardiovascular journals. He is an elected fellow of the ESC.

Arnoud-van-t-hof_5dca72d690a3c

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht

  • 2020
    • Donders, H. C. M., IJzerman, L. M., Soffner, M., van't Hof, A. W. J., Loos, B. G., & de Lange, J. (2020). Elevated Coronary Artery Calcium scores are associated with tooth loss. PLOS ONE, 15(12), Article 0243232. https://doi.org/10.1371/journal.pone.0243232
    • Schiffer, V. M. M. M., Janssen, E. B. N. J., van Bussel, B. C. T., Jorissen, L. L. M., Tas, J., Sels, J.-W. E. M., Bergmans, D. C. J. J., Dinh, T. H. T., van Kuijk, S. M. J., Hana, A., Mehagnoul-Schipper, J., Scheeren, C. I. E., Mesotten, D., Stessel, B., Marx, G., Hof, A. W. J. V. T., Spaanderman, M. E. A., van Mook, W. N. K. A., van der Horst, I. C. C., & Ghossein-Doha, C. (2020). The "sex gap" in COVID-19 trials: a scoping review. EClinicalMedicine, 29-30, Article 100652. https://doi.org/10.1016/j.eclinm.2020.100652
    • Marcin, T., Eser, P., Prescott, E., Prins, L. F., Kolkman, E., Bruins, W., van der Velde, A. E., Pena Gil, C., Iliou, M.-C., Ardissino, D., Zeymer, U., Meindersma, E. P., Van't Hof, A. W. J., de Kluiver, E. P., & Wilhelm, M. (2020). Training intensity and improvements in exercise capacity in elderly patients undergoing European cardiac rehabilitation - the EU-CaRE multicenter cohort study. PLOS ONE, 15(11), Article e0242503. https://doi.org/10.1371/journal.pone.0242503
    • Prescott, E., Eser, P., Mikkelsen, N., Holdgaard, A., Marcin, T., Wilhelm, M., Gil, C. P., Gonzalez-Juanatey, J. R., Moatemri, F., Iliou, M. C., Schneider, S., Schromm, E., Zeymer, U., Meindersma, E. P., Crocamo, A., Ardissino, D., Kolkman, E. K., Prins, L. F., van der Velde, A. E., ... de Kluiver, E. P. (2020). Cardiac rehabilitation of elderly patients in eight rehabilitation units in western Europe: Outcome data from the EU-CaRE multi-centre observational study. European Journal of Preventive Cardiology, 27(16), 1716-1729. Article 2047487320903869. https://doi.org/10.1177/2047487320903869
    • Marcin, T., Eser, P., Prescott, E., Mikkelsen, N., Prins, L. F., Kolkman, E. K., Lado-Baleato, O., Cardaso-Suarez, C., Bruins, W., van der Velde, A. E., Gil, C. P., Iliou, M. C., Ardissino, D., Zeymer, U., Meindersma, E. P., Van't Hof, A. W. J., de Kluiver, E. P., & Wilhelm, M. (2020). Predictors of pre-rehabilitation exercise capacity in elderly European cardiac patients - The EU-CaRE study. European Journal of Preventive Cardiology, 27(16), 1702-1712. Article 2047487319894676. https://doi.org/10.1177/2047487319894676
    • Brouwer, J., Nijenhuis, V. J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., Frambach, P., De Bruyne, B., van Houwelingen, G. K., Van der Heyden, J. A. S., Tousek, P., van der Kley, F., Buysschaert, I., Schotborgh, C. E., Ferdinande, B., van der Harst, P., Roosen, J., Peper, J., Thielen, F. W. F., ... ten Berg, J. M. (2020). Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. New England Journal of Medicine, 383(15), 1447-1457. https://doi.org/10.1056/nejmoa2017815
    • van't Hof, A., & Crea, F. (2020). Invasive or Conservative Strategy for Stable Coronary Disease. New England Journal of Medicine, 383(10), e66(2). https://doi.org/10.1056/nejmc2024008
    • Storey, R. F., Gurbel, P. A., Ten Berg, J., Bernaud, C., Dangas, G. D., Frenoux, J.-M., Gorog, D. A., Hmissi, A., Kunadian, V., James, S. K., Tanguay, J.-F., Tran, H., Trenk, D., Ufer, M., Van der Harst, P., Van't Hof, A. W. J., & Angiolillo, D. J. (2020). Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. European Heart Journal, 41(33), 3132-3140. Article ehz807. https://doi.org/10.1093/eurheartj/ehz807
    • Hermanides, R. S., Kennedy, M. W., Kedhi, E., van Dijk, P. R., Timmer, J. R., Ottervanger, J. P., Dambrink, J.-H., Gosselink, A. T. M., Roolvink, V., Miedema, K., Slingerland, R. J., Koopmans, P., Bilo, H. J. G., & van 't Hof, A. W. J. (2020). Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group. European Heart Journal: Acute Cardiovascular Care, 9(6), 616-625. https://doi.org/10.1177/2048872619849921
    • van Dongen, D. N., Fokkert, M. J., Tolsma, R. T., van der Sluis, A., Slingerland, R. J., Badings, E. A., van 't Hof, A. W. J., & Ottervanger, J. P. (2020). Accuracy of pre-hospital HEART score risk classification using point of care versus high sensitive troponin in suspected NSTE-ACS. American Journal of Emergency Medicine, 38(8), 1616-1620. https://doi.org/10.1016/j.ajem.2019.158448
    • Hoedemaker, N. P. G., Roolvink, V., de Winter, R. J., van Royen, N., Fuster, V., Garcia-Ruiz, J. M., Er, F., Gassanov, N., Hanada, K., Okumura, K., Ibanez, B., van 't Hof, A. W., & Damman, P. (2020). Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials. European Heart Journal: Acute Cardiovascular Care, 9(5), 469-477. https://doi.org/10.1177/2048872619830609
    • Vranken, N. P. A., Pustjens, T. F. S., Kolkman, E., Hermanides, R. S., Bekkers, S. C. A. M., Smulders, M. W., van Cauteren, Y. J. M., Heijman, J., Rasoul, S., Ottervanger, J. P., & van't Hof, A. W. J. (2020). MINOCA: The caveat of absence of coronary obstruction in myocardial infarction. IJC Heart & Vasculature, 29, Article 100572. https://doi.org/10.1016/j.ijcha.2020.100572
    • van Dongen, D. N., Tolsma, R. T., Fokkert, M. J., Badings, E. A., van der Sluis, A., Slingerland, R. J., van 't Hof, A. W. J., van 't Riet, E., & Ottervanger, J. P. (2020). Referral decisions based on a prehospital HEART score in suspected non-ST-elevation acute coronary syndrome: design of the FamouS Triage 3 study. Future Cardiology, 16(4), 217-226. https://doi.org/10.2217/fca-2019-0030
    • Nijenhuis, V. J., Brouwer, J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., Frambach, P., De Bruyne, B., van Houwelingen, G. K., Van der Heyden, J. A. S., Tousek, P., van der Kley, F., Buysschaert, I., Schotborgh, C. E., Ferdinande, B., van der Harst, P., Roosen, J., Peper, J., Thielen, F. W. F., ... ten Berg, J. M. (2020). Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. New England Journal of Medicine, 382(18), 1696-1707. https://doi.org/10.1056/nejmoa1915152
    • d'Alessandro, E., Becker, C., Bergmeier, W., Bode, C., Bourne, J. H., Brown, H., Buller, H. R., ten Cate-Hoek, A. J., ten Cate, V., van Cauteren, Y. J. M., Cheung, Y. F. H., Cleuren, A., Coenen, D., Crijns, H. J. G. M., de Simone, I., Dolleman, S. C., Klein, C. E., Fernandez, D. I., Granneman, L., ... Scientific Reviewer Committee (2020). Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis, 120(4), 538-564. https://doi.org/10.1055/s-0040-1708035
    • Scheenstra, B., van't Hof, A., Spreeuwenberg, M., & Linz, D. (2020). From calculating cardiovascular risk factors in Honduras towards a universal cardiovascular risk model. IJC Heart & Vasculature, 27, Article 100485. https://doi.org/10.1016/j.ijcha.2020.100485
    • Eser, P., Marcin, T., Prescott, E., Prins, L. F., Kolkman, E., Bruins, W., van der Velde, A. E., Pena-Gil, C., Iliou, M. C., Ardissino, D., Zeymer, U., Meindersma, E. P., Van'tHof, A. W. J., de Kluiver, E. P., Laimer, M., & Wilhelm, M. (2020). Clinical outcomes after cardiac rehabilitation in elderly patients with and without diabetes mellitus: The EU-CaRE multicenter cohort study. Cardiovascular Diabetology, 19(1), Article 37. https://doi.org/10.1186/s12933-020-01013-8
    • Claassens, D. M. F., Tavenier, A. H., Hermanides, R. S., Vos, G. J. A., Hinrichs, D. L., Bergmeijer, T. O., van't Hof, A. W. J., Deneer, V. H. M., & ten Berg, J. M. (2020). Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMI. Jacc-Cardiovascular Interventions, 13(5), 663-665. https://doi.org/10.1016/j.jcin.2020.01.001
    • van Dongen, D. N., Tolsma, R. T., Fokkert, M. J., Badings, E. A., van der Sluis, A., Slingerland, R. J., van 't Hof, A. W. J., & Ottervanger, J. P. (2020). Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study. European Heart Journal: Acute Cardiovascular Care, 9(1_SUPPL), 5-12. https://doi.org/10.1177/2048872618813846
    • Pustjens, T. F. S., Appelman, Y., Damman, P., ten Berg, J. M., Jukema, J. W., de Winter, R. J., Agema, W. R. P., van der Wielen, M. L. J., Arslan, F., Rasoul, S., & van't Hof, A. W. J. (2020). Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group. Netherlands Heart Journal, 28(3), 116-130. https://doi.org/10.1007/s12471-019-01344-6
    • Zwart, B., ten Berg, J. M., van't Hof, A. W., Tonino, P. A. L., Appelman, Y., Liem, A. H., Arslan, F., Waltenberger, J., Jukema, J. W., de Winter, R. J., & Damman, P. (2020). Indications for an early invasive strategy in NSTE-ACS patients. Netherlands Heart Journal, 28(3), 131-135. https://doi.org/10.1007/s12471-019-01337-5
    • Bauer, T., Zeymer, U., Diallo, A., Vicaut, E., Bolognese, L., Cequier, A., Huber, K., Montalescot, G., Hamm, C. W., van 't Hof, A. W., & ATLANTIC Investigators (2020). Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study. Catheterization and Cardiovascular interventions, 95(3), 494-500. https://doi.org/10.1002/ccd.28318
    • Pustjens, T. F. S., Streukens, B., Vainer, J., Gho, B., Ruiters, A. W., Stein, M., Ilhan, M., Veenstra, L., Theunissen, R., Bekkers, S. C. A. M., Van't Hof, A. W. J., & Rasoul, S. (2020). Design and rationale of ischaemia-driven complete revascularisation versus usual care in patients with non-ST-elevation myocardial infarction and multivessel coronary disease: the South Limburg Myocardial Infarction (SLIM) trial. Netherlands Heart Journal, 28(2), 75-80. https://doi.org/10.1007/s12471-019-01332-w
    • Pustjens, T. F. S., Appelman, Y., Damman, P., ten Berg, J. M., Jukema, J. W., de Winter, R. J., Agema, W. R. P., van der Wielen, M. L. J., Arslan, F., Rasoul, S., & van't Hof, A. W. J. (2020). Correction to: Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group. Netherlands Heart Journal, 28(1), 59-59. https://doi.org/10.1007/s12471-019-01358-0
    • Tavenier, A. H., Hermanides, R. S., Fabris, E., Lapostolle, F., Silvain, J., ten Berg, J. M., Lassen, J. F., Bolognese, L., Cantor, W. J., Cequier, A., Chettibi, M., Goodman, S. G., Hammett, C. J., Huber, K., Janzon, M., Merkely, B., Storey, R. F., Zeymer, U., Ecollan, P., ... ATLANTIC Investigators (2020). Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial. Thrombosis and Haemostasis, 120(1), 65-74. https://doi.org/10.1055/s-0039-1700546
    • Fabris, E., Hermanides, R., Roolvink, V., Ibanez, B., Ottervanger, J. P., Pizarro, G., van Royen, N., Mateos-Rodriguez, A., Dambrink, J. H., Albarran, A., Fernandez-Aviles, F., Botas, J., Remkes, W., Hernandez-Jaras, V., Kedhi, E., Zamorano, J., Alfonso, F., Garcia-Lledo, A., van Leeuwen, M., ... van 't Hof, A. W. J. (2020). Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial. Open Heart, 7(2), Article 001316. https://doi.org/10.1136/openhrt-2020-001316
  • 2019
    • van Dongen, D. N., Ottervanger, J. P., Tolsma, R., Fokkert, M., van der Sluis, A., van 't Hof, A. W. J., Badings, E., & Slingerland, R. J. (2019). In-Hospital Healthcare Utilization, Outcomes, and Costs in Pre-Hospital-Adjudicated Low-Risk Chest-Pain Patients. Applied Health Economics and Health Policy, 17(6), 875-882. https://doi.org/10.1007/s40258-019-00502-6
    • Marchal, S., Hollander, M., Schoenmakers, M., Schouwink, M., Timmer, J. R., Bilo, H. J. G., Schwantje, O., van 't Hof, A. W. J., & Hoes, A. W. (2019). Design of the ZWOT-CASE study: an observational study on the effectiveness of an integrated programme for cardiovascular risk management compared to usual care in general practice. BMC Family Practice, 20(1), Article 149. https://doi.org/10.1186/s12875-019-1039-z
    • Fabris, E., De Luca, A., Vitrella, G., Stolfo, D., Mase, M., Korcova, R., Merlo, M., Rakar, S., van't Hof, A. W. J., Kedhi, E., Perkan, A., & Sinagra, G. (2019). Treatment of Functional Mitral Regurgitation in Heart Failure. Current Cardiology Reports, 21(11), Article 139. https://doi.org/10.1007/s11886-019-1221-x
    • Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., Asselbergs, F. W., Mosterd, A., Herrman, J.-P. R., Dewilde, W. J. M., Janssen, P. W. A., Kelder, J. C., Postma, M. J., de Boer, A., Boersma, C., Deneer, V. H. M., & ten Berg, J. M. (2019). A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI. New England Journal of Medicine, 381(17), 1621-1631. https://doi.org/10.1056/NEJMoa1907096
    • Prescott, E., Mikkelsen, N., Holdgaard, A., Eser, P., Marcin, T., Wilhelm, M., Gil, C. P., González-Juanatey, J. R., Moatemri, F., Iliou, M. C., Schneider, S., Schromm, E., Zeymer, U., Meindersma, E. P., Ardissino, D., Kolkman, E. K., Prins, L. F., van der Velde, A. E., Van 't Hof, A. W., & de Kluiver, E. P. (2019). Cardiac rehabilitation in the elderly patient in eight rehabilitation units in Western Europe: Baseline data from the EU-CaRE multicentre observational study. European Journal of Preventive Cardiology, 26(10), 1052-1063. https://doi.org/10.1177/2047487319839819
    • Hoedemaker, N. P. G., Damman, P., Ottervanger, J. P., Dambrink, J. H. E., Gosselink, A. T. M., Kedhi, E., Kolkman, E., de Winter, R. J., & van't Hof, A. W. J. (2019). Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. European Heart Journal-Cardiovascular Pharmacotherapy, 5(3), 127-138. https://doi.org/10.1093/ehjcvp/pvy030
    • Piccolo, R., Bonaa, K. H., Efthimiou, O., Varenne, O., Oliva, B., Urban, P., Kaiser, C., Remkes, W., Raber, L., de Belder, A., van 't Hof, A., Stankovic, G., Lemos, P. A., Wilsgaard, T., Reifart, J., Rodriguez, A. E., Ribeiro, E. E., Serruys, P. W., Abizaid, A., ... Valgimigli, M. (2019). Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet, 393(10190), 2503-2510. https://doi.org/10.1016/S0140-6736(19)30474-X
    • Gargiulo, G., da Costa, B. R., Frigoli, E., Palmieri, C., Nazzaro, M. S., Falcone, C., Liso, A., Vigna, C., Abate, F., Comeglio, M., Diletti, R., Gabrielli, G., Di Lorenzo, E., Mazzarotto, P., Zimarino, M., Moretti, C., Colombo, A., Penzo, C., Pasquetto, G., ... Valgimigli, M. (2019). Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial. Eurointervention, 15(3), e269-e278. https://doi.org/10.4244/EIJ-D-18-00247
    • Fabris, E., van't Hof, A., Hamm, C. W., Lapostolle, F., Lassen, J. F., Goodman, S. G., ten Berg, J. M., Bolognese, L., Cequier, A., Chettibi, M., Hammett, C. J., Huber, K., Janzon, M., Merkely, B., Storey, R. F., Zeymer, U., Cantor, W. J., Kerneis, M., Diallo, A., ... ATLANTIC Investigators (2019). Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial. Catheterization and Cardiovascular interventions, 93(7), E369-E377. https://doi.org/10.1002/ccd.27921
    • ten Haaf, M. E., Bax, M., ten Berg, J. M., Brouwer, J., van 't Hof, A., van der Schaaf, R. J., Stella, P. R., Gin, R. M. T. J., Tonino, P. A., de Vries, A. G., Zijlstra, F., Boersma, E., & Appelman, Y. (2019). Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands. Netherlands Heart Journal, 27(5), 263-271. https://doi.org/10.1007/s12471-019-1271-0
    • Fabris, E., van't Hof, A., Hamm, C. W., Lapostolle, F., Lassen, J. F., Goodman, S. G., ten Berg, J. M., Bolognese, L., Cequier, A., Chettibi, M., Hammett, C. J., Huber, K., Janzon, M., Merkely, B., Storey, R. F., Zeymer, U., Cantor, W. J., Tsatsaris, A., Kerneis, M., ... ATLANTIC Investigators (2019). Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial. European Heart Journal: Acute Cardiovascular Care, 8(3), 208-217. https://doi.org/10.1177/2048872617727722
    • Fabris, E., Ottervanger, J. P., Hermanides, R. S., ten Berg, J. M., Sinagra, G., Koopmans, P. C., Giannitsis, E., Hamm, C., & van 't Hof, A. W. J. (2019). Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention. Catheterization and Cardiovascular interventions, 93(5), E293-E297. https://doi.org/10.1002/ccd.28043
    • Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Rasoul, S., Slingerland, R. J., Tolsma, R., van Workum, S., Kedhi, E., & van 't Hof, A. W. J. (2019). A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME3) trial. Netherlands Heart Journal, 27(4), 185-190. https://doi.org/10.1007/s12471-019-1241-6
    • Lapostolle, F., van't Hof, A. W., Hamm, C. W., Stibbe, O., Ecollan, P., Collet, J.-P., Silvain, J., Lassen, J. F., Heutz, W. M. J. M., Bolognese, L., Cantor, W. J., Cequier, A., Chettibi, M., Goodman, S. G., Hammett, C., Huber, K., Janzon, M., Merkely, B., Storey, R. F., ... ATLANTIC Investigators (2019). Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine. American Journal of Cardiovascular Drugs, 19(2), 173-183. https://doi.org/10.1007/s40256-018-0305-0
    • van 't Hof, A. W. J., & Badings, E. (2019). NSTEMI treatment: should we always follow the guidelines?Netherlands Heart Journal, 27(4), 171-175. https://doi.org/10.1007/s12471-019-1244-3
    • Vainer, J., Lux, A., Ilhan, M., Theunissen, R. A. L. J., Aydin, S., & van 't Hof, A. W. J. (2019). Smart solution for hard times: successful lithoplasty of an undilatable lesion. Netherlands Heart Journal, 27(4), 216-217. https://doi.org/10.1007/s12471-019-1261-2
    • Badings, E. A., Hermanides, R. S., Van Der Sluis, A., Dambrink, J. H. E., Gosselink, A. T. M., Kedhi, E., Ottervanger, J. P., Roolvink, V., Remkes, W. S., Van't Riet, E., Suryapranata, H., & Van't Hof, A. W. J. (2019). Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a 'real world' prospective registry. Netherlands Heart Journal, 27(2), 73-80. https://doi.org/10.1007/s12471-018-1212-3
    • Piccolo, R., Bonaa, K. H., Efthimiou, O., Varenne, O., Oliva, B., Urban, P., Kaiser, C., Remkes, W., Raber, L., de Belder, A., van 't Hof, A., Stankovic, G., Lemos, P. A., Wilsgaard, T., Reifart, J., Rodriguez, A. E., Ribeiro, E. E., Serruys, P. W., Abizaid, A., ... Valgimigli, M. (2019). Department of Error: Correction of: Drug-eluting or bare-metal stents for percutaneous coronary intervention : a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet, 393(10190), 2492. https://doi.org/10.1016/S0140-6736(19)31324-8
  • 2018
    • Tavenier, A. H., Hermanides, R. S., Ottervanger, J. P., Ter Horst, P. G. J., Kedhi, E., & van't Hof, A. W. J. (2018). Risks of Opioids in ST-Elevation Myocardial Infarction: A Review. Drug Safety, 41(12), 1303-1308. https://doi.org/10.1007/s40264-018-0710-y
    • van Dongen, D. N., Fokkert, M. J., Tolsma, R. T., Badings, E. A., van der Sluis, A., Slingerland, R. J., van't Hof, A. W. J., & Ottervanger, J. P. (2018). Value of Prehospital Troponin Assessment in Suspected Non-ST-Elevation Acute Coronary Syndrome. American Journal of Cardiology, 122(10), 1610-1616. https://doi.org/10.1016/j.amjcard.2018.07.037
    • Snoek, J. A., Eijsvogels, T. M. H., Van't Hof, A. W. J., Prescott, E., Hopman, M. T., Kolkman, E., & De Kluiver, E. P. (2018). Impact of a Graded Exercise Program on (V) over dot O-2peak and Survival in Heart Failure Patients. Medicine and Science in Sports and Exercise, 50(11), 2185-2191. https://doi.org/10.1249/MSS.0000000000001688
    • de Winter, R. J., Chandrasekhar, J., Kalkman, D. N., Aquino, M. B., Woudstra, P., Beijk, M. A., Sartori, S., Baber, U., Tijssen, J. G., Koch, K. T., Dangas, G. D., Colombo, A., Mehran, R., van 't Hof, A., & MASCOT (2018). 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. Jacc-Cardiovascular Interventions, 11(19), 1969-1978. https://doi.org/10.1016/j.jcin.2018.04.038
    • Albani, S., Fabris, E., Doimo, S., Barbati, G., Perkan, A., Merlo, M., Gatti, G., Di Lenarda, A., van't Hof, A. W. J., Maras, P., & Sinagra, G. (2018). Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization. European Heart Journal-Cardiovascular Pharmacotherapy, 4(4), 195-201. https://doi.org/10.1093/ehjcvp/pvy017
Overview